Welcome and good morning on our behalf as well. Let's start with a summary of the year 2025. It was a year with market uncertainty and continued dampened demand, although conditions improved throughout the year. We improved operationally and financially gradually during the year, and we also further strengthened our long-term strategic capability as our new segment structure is now fully established.
In terms of financial numbers, order intake grew by 2% in total and by 2% organically. Net sales decreased by 1% in total, of which -2% organically, driven mainly by backlog reductions during 2023 and 2024.
The EBITA margin was 13.8% for the year, excluding extraordinary one-offs. The EBITA margin came in at 14.1%. Cash flow continued at a high level, and the financial position of the group is very strong.
In terms of acquisitions, we acquired 13 well-positioned and profitable companies during the year, with a total annual turnover of 1.3 billion SEK.
The board proposes a dividend of Swedish krona 3.1 per share.
Looking at the Q4 highlights, organic order growth was +3%. Positive development was observed in many companies and all larger customer segments. Three out of five business areas grew organically and the remaining two were stable from last year. More than half of the companies had organic order growth. The strongest demand from customers was within energy, water and wastewater, and infrastructure and construction.
Net sales decreased by 1% in total. Organically, it was unchanged. The reported EBITA margin came in at 13.3% compared to 14.6% for the same period last year. However, underlying EBITA margin was strong at 14.9%. Excluding the extraordinary one-offs in the quarter. And this we will comment more on later in the presentation.
Underlying EBITDA margin last year was 14.3%.
Cash flow from operating activities amounted to 1.6 billion SEK in line with a high level last year, and there were continued inventory reductions from our companies. The acquisition pace was good in Q4, with four announced acquisitions, and the pipeline also remains good. Both short and long term.
Moving on to order intake and sales trends.
Demand continued to improve and was stronger than last year, with positive development in many companies, customer segments and geographies. Development was generally positive in all larger customer segments, and the strongest performance was seen in the energy, water and wastewater sectors, and for companies with customers within infrastructure and construction; order intake improved in the majority of the companies and was up 3% organically. Order intake was in line with sales. Sales, which is good, as book-to-bill is seasonally weaker during the second half of the year.
As you can see on the slide. Currency has a large impact of -4%, which, together with the -1% from divestments, materially impacts total growth on orders and sales. The underlying situation is clearly better, with plus 7% growth in orders and plus 4% in sales. Organic sales development was strongest in the Industrial & Engineering business area, and Infrastructure & Construction also grew organically. While it was weakest in Technology and Systems Solutions.
Looking more specifically at the sales per geographical market, sales to Sweden were flat from last year and down in Denmark due to the high comparables from last year, when we still had some deliveries to Novo Nordisk from the large order we received two years ago. Finland was stable from last year and Norway stronger. Development in Norway is mainly connected to flow technology products for water and wastewater, aquaculture and marine applications, as well as other products for infrastructure customers for the rest of Europe. Sales growth was strong in Benelux, mainly due to good development within valves for power generation and also single-use products for pharma production. UK, Ireland and Germany were down as a result of the generally weaker business climate in those areas.
Sales growth in Switzerland and Austria was strong, with good developments for companies with customers in infrastructure and construction, and medtech and pharmaceuticals.
Sales development in North America and Asia is normally slightly volatile but was down compared to last year and among other things related to companies within Business Area Technology and System Solutions having a weaker demand on the back of the tariff situation. Total EBIT decreased 10% from the same period last year to 1.1 billion SEK, corresponding to an EBITA margin of 13.3%. However, this quarter was strongly affected by extraordinary one-offs, primarily connected to two companies in the UK within business area Technology and System Solutions. Patrick will elaborate a bit more on this later in the presentation, but I want to highlight that they are non-recurring and extraordinary, and you shouldn't expect these types of items from Indutrade, but adjusted for these one-offs, the underlying EBITA margin was strong at 14.9% compared to the underlying EBITA margin of 14.3% last year. The gross margin continued at a high level of 35.4%, and even stronger than last year if you exclude these two UK companies.
Organic expenses are under control. As mentioned earlier, organic sales growth was strongest in the business area Industrial and Engineering, with positive development in many companies, for instance, infrastructure, machinery, and railway rolling stock. Infrastructure and construction also had a slightly positive development. However, from low levels, as the demand has been dampened for many quarters, we saw, for instance, strong development in the water distribution segment. In life science, there was a strong development in several areas, for example single-use companies and broadly in the medtech segment, but was offset by strong comparables connected to sales to Novo Nordisk last year.
As I mentioned earlier. Also, Process, Energy & Water had tough references in many companies, and the main reason for negative development in Business Area Technology and System Solutions relates to project revenue recognition adjustments linked to the UK situation I spoke about earlier. Without those adjustments, the organic development was -2%, partly connected to the lower sales to the US.
Moving into EBITA margin development per business area.
As mentioned, the total gross margin was strong, which is driven by multiple factors like mix and currency. But it's also a sign of quality in our product offerings and strong pricing power. Industrial and Engineering improved the EBITA margin as a result of the strength in gross margin and also leverage on the organic sales growth; Infrastructure and Construction was close to last year's level, but was negatively affected by a lower gross margin in a few companies. Life Science also improved its EBITA margin despite strong sales referencing last year's comparable figures, mainly due to a positive product mix with good sales development from some high-margin companies; Process, Energy & Water and Technology & System Solutions, however, had a weaker EBITA margin compared to last year as a result of organic sales development and slightly higher expense levels.
The one-offs in Technology and System Solutions I mentioned earlier are recognized as group items outside the business area, so no impact on the EBITA margin from that.
In 2025, we welcomed 13 profitable and well-positioned companies to the group, with a total annual turnover of 1.3 billion SEK. The acquisition pace was lower during the first half of the year, but increased significantly during the second half, with ten acquisitions completed in the second half. In the fourth quarter, we announced four acquisitions where the acquisition of ATM Group marked our first acquisition in Spain. ATM is a technical trading company specialized in single use components for life science applications. We have many similar companies in the single use area in other geographies in Europe. So this acquisition is a good example of our ability to expand into new markets in a controlled yet opportunistic way.
We have gradually strengthened our acquisition resources and our business areas work independently with different projects. This, together with business segment leaders being more proactive in the acquisition work and internal pipeline generation, is a strong platform to use in gradually increasing our acquisition pace going forward. The pipeline is good, both short and long term, and I look forward to announcing the first acquisition in 2026 very soon. Looking at the longer trend, we are gradually increasing the number of acquisitions.
Although the number of acquisitions per year can be somewhat volatile.
Looking at the bridge effects from acquisitions, over the last 12 months, we have added over 190 million SEK to the group's EBITDA in 2025.
Furthermore, we can also see that the acquisitions are margin accretive within an accumulated EBITDA margin of 16% for the quarter and 16.4% rolling 12 months. Good to note that this includes transaction costs, so the underlying margin is even higher. By that, I leave the word over to Patrik to comment more on the financial situation.